The Nasdaq notice indicated that, in accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company will be provided 180 calendar days, or until April 10, 2023, to regain compliance. If, at any time before April 10, 2023, the bid price of the Company’s common stock closes at $1.00 per share or more for a minimum of 10 consecutive business days, Nasdaq staff will provide written notification that the Company has achieved compliance with the Bid Price Rule.
If the Company fails to regain compliance with the Bid Price Rule before April 10, 2023, the Company may be eligible for an additional 180-calendar day compliance period. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for Nasdaq, with the exception of the bid price requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. In the event the Company is not eligible for the second grace period, Nasdaq will provide written notice that the Company’s common stock is subject to delisting. If the Company is notified by Nasdaq that its securities will be subject to delisting, the Company may appeal the delisting determination and request a hearing before the Nasdaq Hearings Panel (the “Panel”). If the request for a Panel is timely made, any further suspension or delisting action would be stayed pending the conclusion of the hearing process and expiration of any extension that may be granted by the Panel.
There can be no assurance that the Company will be successful in its efforts to maintain its Nasdaq listing. If the Company’s common stock ceases to be listed for trading on the Nasdaq Capital Market, the Company would expect that its common stock would be traded on one of the three tiered marketplaces of the OTC Markets Group. The Company intends to closely monitor the closing bid price of its common stock and consider all available options to remedy the bid price deficiency to regain compliance with the Bid Price Rule.
Recent YYAI News
- Connexa Announces 1:20 Reverse Split to Remedy Bid Price Delisting Notice • GlobeNewswire Inc. • 06/25/2024 03:52:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 07:45:28 PM
- Connexa Applies for Imminent 1:20 Reverse Split to Remedy Bid Price Delisting Notice • GlobeNewswire Inc. • 06/17/2024 07:45:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 05/28/2024 01:21:39 PM
- Connexa Shareholders Approve Transaction to Acquire Yuanyu Enterprise Management • GlobeNewswire Inc. • 05/17/2024 04:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 01:43:34 PM
- Connexa Shareholders Approve Transaction to Acquire Hong Kong Based Yuanyu Enterprise Management • GlobeNewswire Inc. • 05/17/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 01:30:14 PM
- Connexa Updates Ticker Symbol To Reflect Its Future Business Model. • GlobeNewswire Inc. • 04/22/2024 03:15:00 PM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM